Omeros (OMER) Total Debt Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | -45.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.74% |
| Dec 31, 2025 | -24.51% |
| Sep 30, 2025 | -22.02% |
| Jun 30, 2025 | -7.61% |
| Mar 31, 2025 | -54.41% |
| Dec 31, 2024 | -57.48% |
| Sep 30, 2024 | -70.82% |
| Jun 30, 2024 | -70.12% |
| Mar 31, 2024 | -32.40% |
| Dec 31, 2023 | -32.39% |
| Sep 30, 2023 | 0.61% |
| Jun 30, 2023 | 0.60% |
| Mar 31, 2023 | 0.59% |
| Dec 31, 2022 | 0.58% |
| Sep 30, 2022 | 0.58% |
| Jun 30, 2022 | 0.57% |
| Mar 31, 2022 | 0.56% |
| Dec 31, 2021 | 32.66% |
| Sep 30, 2021 | 34.45% |
| Jun 30, 2021 | 91.33% |
| Mar 31, 2021 | 94.19% |
| Dec 31, 2020 | 49.35% |
| Sep 30, 2020 | 49.46% |
| Jun 30, 2020 | 6.49% |
| Mar 31, 2020 | 4.56% |
| Dec 31, 2019 | 5.57% |
| Sep 30, 2019 | 17.78% |
| Jun 30, 2019 | 17.69% |
| Mar 31, 2019 | 79.71% |
| Dec 31, 2018 | 78.85% |
| Sep 30, 2018 | 59.06% |
| Jun 30, 2018 | 59.44% |
| Mar 31, 2018 | 5.97% |
| Dec 31, 2017 | 5.13% |
| Sep 30, 2017 | 17.97% |
| Jun 30, 2017 | 16.76% |
| Mar 31, 2017 | 61.33% |
| Dec 31, 2016 | 59.93% |
| Sep 30, 2016 | 146.85% |
| Jun 30, 2016 | 127.57% |
| Mar 31, 2016 | 51.99% |
| Dec 31, 2015 | 53.58% |
| Sep 30, 2015 | -12.26% |
| Jun 30, 2015 | -4.94% |
| Mar 31, 2015 | 2.21% |
| Dec 31, 2014 | 58.32% |
| Sep 30, 2014 | 59.56% |
| Jun 30, 2014 | 59.51% |
| Mar 31, 2014 | 59.49% |
| Dec 31, 2013 | 1.96% |
| Sep 30, 2013 | 134.99% |
| Jun 30, 2013 | 96.17% |
| Mar 31, 2013 | 68.74% |
| Dec 31, 2012 | 3.38% |
| Sep 30, 2012 | -42.49% |
| Jun 30, 2012 | -37.66% |
| Dec 31, 2011 | 97.22% |